PF-Atlas › Clinical Trials › NCT06823063

Clinical Trial of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of CTD-ILD

MSC · Phase 1

Registry ID
NCT06823063
Phase
Phase 1
Status
Not yet recruiting
Drug / intervention
MSC
Sponsor
Shanghai IxCell Biotechnology Co., LTD
Start
2025-04-01

About this trial

MSC is evaluated in NCT06823063, a Phase 1 idiopathic pulmonary fibrosis study sponsored by Shanghai IxCell Biotechnology Co., LTD. Current status: Not yet recruiting.

View NCT06823063 on ClinicalTrials.gov →

Explore related

MSC-Derived Extracellular Vesicles — Treatment profileAll MSC trialsAll IPF trials

Related trials

MSC — NCT06788470
Medical disclaimer. This page summarizes public trial data for NCT06823063 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.